D-0549-2024 Class II Terminated
FDA drug recall D-0549-2024 was initiated by RemedyRepack Inc. on May 31, 2024 and is designated Class II. Reason for recall: Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg. The recall status is terminated (terminated Jul 1, 2024). Affected quantity: 8 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 19, 2024
- Initiation Date
- May 31, 2024
- Termination Date
- Jul 1, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8 bottles
Product description
Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA
Reason for recall
Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Distribution pattern
Product was distributed to one medical facility.
Code information
Lot # B2906961-042524, exp. date 02/26/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0549-2024
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026